These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1691885

  • 1. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.
    Rooke R, Tremblay M, Wainberg MA.
    Virology; 1990 May; 176(1):205-15. PubMed ID: 1691885
    [Abstract] [Full Text] [Related]

  • 2. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
    Lambert DM, Bartus H, Fernandez AV, Bratby-Anders C, Leary JJ, Dreyer GB, Metcalf BW, Petteway SR.
    Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
    [Abstract] [Full Text] [Related]

  • 3. Sodium pentosan polysulfate (PPS), an anti-HIV agent also exhibits synergism with AZT, lymphoproliferative activity, and virus enhancement.
    Anand R, Nayyar S, Galvin TA, Merril CR, Bigelow LB.
    AIDS Res Hum Retroviruses; 1990 May; 6(5):679-89. PubMed ID: 1694454
    [Abstract] [Full Text] [Related]

  • 4. In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovudine (ZDV).
    Masquelier B, Combeau T, Poveda JD, Delord B, Pellegrin JL, Sallafranque-Andreola ML, Tarrago-Litvak L, Fleury HJ.
    J Acquir Immune Defic Syndr (1988); 1991 May; 4(5):499-505. PubMed ID: 1707962
    [Abstract] [Full Text] [Related]

  • 5. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
    Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS.
    Science; 1989 May 05; 244(4904):575-7. PubMed ID: 2470148
    [Abstract] [Full Text] [Related]

  • 6. Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages.
    Geleziunas R, Arts EJ, Boulerice F, Goldman H, Wainberg MA.
    Antimicrob Agents Chemother; 1993 Jun 05; 37(6):1305-12. PubMed ID: 8392310
    [Abstract] [Full Text] [Related]

  • 7. Modification of human immunodeficiency viral replication by pine cone extracts.
    Lai PK, Donovan J, Takayama H, Sakagami H, Tanaka A, Konno K, Nonoyama M.
    AIDS Res Hum Retroviruses; 1990 Feb 05; 6(2):205-17. PubMed ID: 1691654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of reverse transcriptase activity and susceptibility to other nucleosides of AZT-resistant variants of HIV-1. Results from the Canadian AZT Multicentre Study.
    Wainberg MA, Tremblay M, Rooke R, Blain N, Soudeyns H, Parniak MA, Yao XJ, Li XG, Fanning M, Montaner JS.
    Ann N Y Acad Sci; 1990 Feb 05; 616():346-55. PubMed ID: 1706573
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG, MacInnes H, Bennett D, Weinstock H, Heneine W.
    J Virol; 2004 Jul 05; 78(14):7545-52. PubMed ID: 15220429
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.
    Stine KC, Tyler DS, Stanley SD, Bartlett JA, Bolognesi DP, Weinhold KJ.
    Cell Immunol; 1991 Aug 05; 136(1):165-72. PubMed ID: 1905587
    [Abstract] [Full Text] [Related]

  • 17. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
    Bryant ML, Ratner L, Duronio RJ, Kishore NS, Devadas B, Adams SP, Gordon JI.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2055-9. PubMed ID: 2006142
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-HIV-1 activity of 3'-azido-3'-deoxythymidine (AZT) in primary mononuclear phagocytes.
    Beenhouwer DO, Rankin JA, Mellors JW.
    Antiviral Res; 1992 Jul 01; 19(1):43-54. PubMed ID: 1444321
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 gag proteins in virions and in infected cell fractions.
    Sharova NK, Grigor'ev VB, Bukrinskaya AG.
    Biomed Sci; 1991 Jul 01; 2(3):279-84. PubMed ID: 1751761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.